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Abstract
The association between lack of thyroid hormones and cardiac dysfunction has been well described. We report
two new cases of patients with dilated cardiomyopathy (DCM), revealing a periphery hypothyroidism and for
whom cardiac function significantly improved after L thyroxin substitutive treatment. Our cases highlight the
necessity to perform thyroid function testing to investigate the etiology of non ischemic DCM.
Introduction
Dilated cardiomyopathy (DCM) is a heart muscle disor-
der defined by the presence of a dilated and poorly func-
tioning left ventricle in the absence of abnormal loading
conditions (hypertension, valve disease) or ischemic heart
disease sufficient to cause global systolic impairment [1].
In the majority of patients no identifiable cause is found
hence the term “idiopathic” dilated cardiomyopathy
(IDC). However, in a rare occasions DCM could be asso-
ciated to variety of pathologies. A link between CMD and
hypothyroidism was first reported in 1918 in four
patients with heart failure refractory to digitalis and
diuretics treated successfully with substitutive hormonal
therapy [2]. Since this first description few other cases
have been published.
We report, two cases of hypothyroidism revealed by a
DCM.
Observations
First case
A 20 years old man, without any previous medical his-
tory, was admitted for chest pain and dyspnea. One year
earlier, the patient developed an important muscle weak-
ness and a weight gain. On examination the patient was
obese, with a body mass index (BMI) at 35.4 kg/m
2, his
skin was pale, dry and infiltrated with edema. Blood pres-
sure was at 120/80 mmHg, the pulse was at 50 b/mn and
heart sounds were distant. Chest X ray showed moderate
cardiomegaly with a cardiothoracic ratio of 0.59. Cardiac
ultrasound revealed a DCM with a severe left ventricle
dysfunction (ejection fraction at 20%) and a global hypo-
kinesis. In addition, there was a moderate pericardial
effusion.
Biological tests showed high cholesterol and triglyceride
level respectively at 6.72 mmol/l and 3.72 mmol/l, hypona-
tremia (132 mmol/l), elevated transaminases (SGOT 52
UI/l and SGPT 86 UI/l) and a raised creatinine phosphoki-
nase level (475 UI/l). Thyroid hormone’sd o s a g es h o w e d
decrease of free thyroxine level (T4 = 0.72 ng/ml) and
an elevation of thyroid stimulating hormone (TSH =
369.5 mUI/l) supporting peripheral origin of hypothyroid-
ism. The thyroid gland was enlarged, heterogeneous and
multinodular on ultrasound imaging. The anti-thyroperox-
idase and anti-microsomial antibodies were positive. The
final diagnosis was Hashimoto thyroiditis. The patient was
treated with substitutive hormonal treatment with thyr-
oxin at an initial dose of 25 μg/day and then progressively
increased until a dosage of 150 μg/day. Three months
after, cardiac ultrasound showed a significant improve-
ment of the left ventricle systolic ejection fraction to 47%
(Table 1).
Second case
A 34 years old man was hospitalized to investigate his
DCM recently discovered. His medical history was
marked by diabetes and heavy smoking. Four months
ago, the patient reported weight gain, constipation and a
nocturnal snoring developed. The physical exam
revealed a patient with a BMI of 31.86 kg/m
2, a blood
pressure at 120/80 mmHg and a mild palpable goiter.
Thyroid hormones dosage revealed a peripheral
hypothyroidism (TSH = 23.4 mUI/l and T4 = 10 ng/ml).
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cle ejection fraction at 25% and a global hypokinesis.
The patient was treated with thyroxin at a dose of 150
μg/day. After three months of follow up, TSH was at 4
mUI/l and echocardiography showed a substantial
improvement of the left ventricule ejection fraction to
49% (table 1).
Discussion
Our patient’s cases confirmed previous reports concern-
ing the potential reversibility of heart failure after substi-
tutive hormonal treatment [3,4].
Thyroid hormones (TH) interact with the sympathova-
gal balance but act also on peripheral vascular resis-
tances. The effect of TH on the cardiovascular system
would be explained by the transcription’sr e g u l a t i o no f
some genes implicated especially in the contractile sys-
tem synthesis. More rapid non genomic effects of the TH
on the ionic channels of cardiomyocyte’s membrane were
identified more recently 5. Hypothyroidism results in a
bradycardia, a decrease of the myocardial contractility
and an increase of the systemic peripheral vascular resis-
tances. A pericardial effusion is the most frequent cardiac
manifestation. Hypothyroidism is associated with an
increased risk for atherosclerosis and ischemic heart dis-
ease and is now considered as proatherosclerosis factor
[6,7]. Many of the cardiac manifestations of thyroid dys-
function are associated with alterations in T3-mediated
gene expression 8,. In hypothyroidism, although cardiac
output is reduced, heart failure is relatively rare because
there is a lower oxygen demand in the periphery 9. In
our two patients, family history was against inherited
causes. There were no histories of drug abuse, nor alco-
hol or toxic substances addiction. Personal history and
clinical exam ruled out nutritional deficiency, while nega-
t i v eH I Va n dH C Vs e r o l o g i e se liminated potential viral
causes. Our observation highlighted the importance of
hormone dosage in first assessment of DCM even in the
absence of major symptoms of TH, because clinical pre-
sentation is sometimes not obvious and the diagnosis can
only be made by thyroid function testing. Fortunately,
the diagnosis of hypothyroidism was clinically evident in
our two patients and confirmed by hormone study. The
second challenge is to know whether TH is an occasional
association with DCM or a cause of it [8]. The improve-
ment of the cardiac function after hormonal treatment is
an important argument in favor of the implication of
hypothyroidism in the genesis of DCM in our patients.
Conclusion
DCM is usually idiopathic disease with progressive and
an irreversible poor prognosis out come. In contrast, in
some cases, DCM can be secondary to various causes
such as hypothyroidism and hormonal treatment with L
thyroxin can significantly improve myocardial function.
Hence, thyroid function tests should be systematically
performed in all patients with DCM in order to rule out
a hypothyroidism.
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Table 1 Biological tests and cardiac ultrasound results before and after substitutive treatment for 2 patients
Before substitutive treatment After substitutive treatment (12 weeks) Reference
ranges
TSH
Patient 1 396,5 24 0,25 - 4 (mUI/l)
Patient 2 23.4 5
Hemoglobin
Patient 1 11.2 12.3 13-16 g/dl
Patient 2 13.1 13.2
CPK
Patient 1 496 100 < 250 (UI/l)
Patient 2 550 230
Cholesterolemia
Patient 1 6,72 5.8 < 5,5 (mmol/l)
Patient 2 7.1 5,7
Ejection fraction
Patient 1 20% 49% 55%
Patient 2 25% 47%
TSH: thyroid stimulating hormone
CPK: creatin phosphokinase
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